Home  »  Financial News   »  How Do Analysts Feel About Charles River Laborator...

How Do Analysts Feel About Charles River Laboratories International Inc. (CRL)?

How have the shares performed?

Charles River Laboratories International Inc. (CRL) saw an uptrend of 2.37% in the recent trading with $332.20 being its most recent. The current price level -4.85% lower than the highest price of $349.13 marked by the stock while trading over the past 52-weeks, whereas it is 101.21% higher than the lowest price of $165.10 the company dropped to over past 52-weeks. The latest news story on CRL appeared in Business Wire under the title “Charles River Laboratories to Host Virtual Investor Day” on May-26-21.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Squeezing the time span to 30 day period shows us the stock is currently trading -4.85% below one month high and is +6.10% above of the lowest during that time. Looking into the simple moving average, Charles River Laboratories International Inc. (CRL)’s stock stands at a SMA-50 of $315.48 while that of 5-day is reading $328.93.

Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and CRL’s SMA-200 as of now is $263.54.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 19 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.80 for the stock.

Charles River Laboratories International Inc. Earnings – What Happened With CRL

Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Charles River Laboratories International Inc. (CRL) last released financial results for the quarter that ended 3/30/2021, posting a surprise factor of 15.50% for net revenue. During the reported three-month period, company’s sales were $824.57 billion while analysts on average were estimating the same to be $873.29 million.

CRL – Charles River Laboratories International Inc. Stock Earnings Estimates

The perspective of Charles River Laboratories International Inc. (NYSE:CRL)’s current quarter earnings identifies that analysts are in consensus over the estimate of 2.19 for stock’s EPS in the current quarter. 13 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was 2.53.

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 49.98 million. CRL does have institutional investors; and they hold 97.30% of the stock.

Charles River Laboratories International Inc. – Insider Activity and Holdings

Moreover, the latest SEC filings also revealed that stock came across 25 new insider purchases involving 42,801 shares. On the other hand, CRL declared 252,183 shares have been sold in 115 insider transactions over the past three months.

As on Mar 30, 2021, Blackrock Inc. was the top most holder in Charles River Laboratories International Inc. (NYSE:CRL) with an ownership of 5.59 million shares of the company or 11.13% of the stake worth $1.62 billion. The filing also reveals Vanguard Group, Inc. (The) as the second largest holder in the company with a control over 10.26% of the outstanding shares. Its stake is worth $1.49 billion for having 5.16 million shares in hand.

FMR, LLC also came holding a key position in the company during the recent quarter and it now holds 4.04% of the outstanding shares. With this there are now 735 institutions which have possession in CRL’s shares.

Currently, the stock has been recommended as Strong Buy by 19 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.80 for the stock.

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Charles River Laboratories International Inc. was 1.43 while posting a debt to equity ratio of 1.01. The count was 98.61 for long-term debt to equity ratio.

Charles River Laboratories International Inc.’s return on equity, or ROE, is 18.90%, compared to the industry average of -0.32% for Healthcare – Diagnostics & Research. Although this indicates that CRL uses its equity well, the metric will vary significantly depending on the industry.

Technical Analysis of Charles River Laboratories International Inc. (NYSE:CRL) stock

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Charles River Laboratories International Inc. (CRL), we notice that the stock’s 20-day average volume is at 1,212,050 shares and 100% of short term indicators are suggesting the stock as Buy. Medium term indicators at an average of 100% are spotting the stock at Buy with its 50-day average volume of 675,766 shares. And to end, CRL’s 100-day average volume is 495,846 shares with 100% of the long-term indicators pointing towards Buy for the stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam